Visualize HL7 Example and Test Instances (vi7eti)

Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/

Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.

BACK TO LIST

Patient
Name:	Hayward, Tom
DOB:	07-APR-1975 (Age: 50)
Gender:	male
Address:	391 Dean locks M1 Manchester (United Kingdom)
ID:	3376-612163-7 (ECI)

Report
Date:	03-JAN-2019

Laboratory
dr Ample, Ex Laboratoire Central Européenne Boulevard du Jardin Botanique 32 1000 Brussels (Belgium)

Requested by
Cornbrook Medical Practice City Road 204 M3 3 Manchester (United Kingdom)

Specimen
Collected:	03-JAN-2019

Chemistry

Test	03-JAN-2019	Reference Range	Unit
Glucose [Mass/volume] in Blood	73.2	70 - 100	mg/dL
Urea nitrogen [Mass/volume] in Blood	14.6	7 - 20	mg/dL
Creatinine [Mass/volume] in Blood	3.2 H	0.6 - 1.2	mg/dL
Calcium [Mass/volume] in Blood	9.8	8.5 - 10.5	mg/dL
Sodium [Moles/volume] in Blood	138.3	135 - 145	mmol/L
Potassium [Moles/volume] in Blood	4.2	3.5 - 5.1	mmol/L
Chloride [Moles/volume] in Blood	107.6 H	98 - 107	mmol/L
Carbon dioxide, total [Moles/volume] in Blood	26.4	22 - 29	mmol/L
Protein [Mass/volume] in Serum or Plasma	7.9	6.0 - 8.3	g/dL
Albumin [Mass/volume] in Serum or Plasma	4.0	3.5 - 5.5	g/dL
Globulin [Mass/volume] in Serum by calculation	3.0 L	20 - 39	g/L
Bilirubin.total [Mass/volume] in Serum or Plasma	0.1 L	0.3 - 1.2	mg/dL
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma	32.9 L	39 - 117	U/L
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma	55.9 H	10 - 40	U/L
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma	36.1	10 - 40	U/L
Cholesterol [Mass/volume] in Serum or Plasma	195.5	125 - 200	mg/dL
Triglyceride [Mass/volume] in Serum or Plasma	163.3 H	0 - 150	mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay	93.2	0 - 100	mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma	59.6	40 - 60	mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows elevated creatinine, suggesting impaired renal function, and mildly high ALT, indicating possible liver involvement. Triglycerides are slightly elevated, which may increase cardiovascular risk. Low globulin, total bilirubin, and alkaline phosphatase are noted but of unclear clinical significance. Other parameters are within normal limits. Correlation with clinical findings and further evaluation of renal and liver function are recommended.

Conclusion and Recommendations based on this report and previous findings known to us

The patient shows elevated creatinine, suggesting impaired renal function, and mildly high ALT, indicating possible liver involvement. Triglycerides are slightly elevated, which may increase cardiovascular risk. Low globulin, total bilirubin, and alkaline phosphatase are noted but of unclear clinical significance. Other parameters are within normal limits. Correlation with clinical findings and further evaluation of renal and liver function are recommended.